# Cumberland Pharmaceuticals Inc: Form 8-K, filed Nov 24, 2025

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2025-11-24
- Accepted by EDGAR: Nov 21, 2025, 20:26 ET
- Period: 2025-11-18
- Accession: 0001087294-25-000023
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000108729425000023/cpix-20251118.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000108729425000023/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000108729425000023/cpix-20251118.htm

Filed Nov 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001087294-25-000023. Last ingested by Listed: Nov 14, 2026, 23:39 ET. No prices; not investment advice.
